StockMacro
Menu

Bristol-Myers Squibb

$58.80 +1.3% in 6 monthsMarket cap $120.2B

BMY on XNYS, Health Care, Bristol-Myers Squibb Co., job postings

Measures activity, not value. Not investment advice.

Layoff notice covers 265 workers while 12-month profit rose 53% and the stock gained 28% in a year.

  • GoodLatest quarter revenue up 6.9% to $13.1B
  • WatchPast layoff-notice filers beat sector by median 11.0 points in 12 months

Written by AI from the data on this page, 21 Nov 2026. Not investment advice.

Profile and fundamentals

From its SEC filings, 12 months to 30 Sep 2026

Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.

Industry
Pharmaceutical preparations (Health Care)
Employees
32,500
Website
bms.com
Listed
NYSE, US
Last results
29 Oct 2026
Next results
expected around 4 Feb 2027 (an estimate: a year ago it reported on 5 Feb 2026)
Revenue and net income per quarter. Quarter to 30 Sep 2026: revenue $13.1B, net income $2.2B.
Quarter to 31 Dec 2021: revenue $12.0B, net income $2.4BQuarter to 31 Dec 2021: revenue $12.0B, net income $2.4BQuarter to 31 Mar 2022: revenue $11.6B, net income $1.3BQuarter to 31 Mar 2022: revenue $11.6B, net income $1.3BQuarter to 30 Jun 2022: revenue $11.9B, net income $1.4BQuarter to 30 Jun 2022: revenue $11.9B, net income $1.4BQuarter to 30 Sep 2022: revenue $11.2B, net income $1.6BQuarter to 30 Sep 2022: revenue $11.2B, net income $1.6BQuarter to 31 Dec 2022: revenue $11.4B, net income $2.0BQuarter to 31 Dec 2022: revenue $11.4B, net income $2.0BQuarter to 31 Mar 2023: revenue $11.3B, net income $2.3BQuarter to 31 Mar 2023: revenue $11.3B, net income $2.3BQuarter to 30 Jun 2023: revenue $11.2B, net income $2.1BQuarter to 30 Jun 2023: revenue $11.2B, net income $2.1BQuarter to 30 Sep 2023: revenue $11.0B, net income $1.9BQuarter to 30 Sep 2023: revenue $11.0B, net income $1.9BQuarter to 31 Dec 2023: revenue $11.5B, net income $1.8BQuarter to 31 Dec 2023: revenue $11.5B, net income $1.8BQuarter to 31 Mar 2024: revenue $11.9B, net income -$11.9BQuarter to 31 Mar 2024: revenue $11.9B, net income -$11.9BQuarter to 30 Jun 2024: revenue $12.2B, net income $1.7BQuarter to 30 Jun 2024: revenue $12.2B, net income $1.7BQuarter to 30 Sep 2024: revenue $11.9B, net income $1.2BQuarter to 30 Sep 2024: revenue $11.9B, net income $1.2BQuarter to 31 Dec 2024: revenue $12.3B, net income $72.0MQuarter to 31 Dec 2024: revenue $12.3B, net income $72.0MQuarter to 31 Mar 2025: revenue $11.2B, net income $2.5BQuarter to 31 Mar 2025: revenue $11.2B, net income $2.5BQuarter to 30 Jun 2025: revenue $12.3B, net income $1.3BQuarter to 30 Jun 2025: revenue $12.3B, net income $1.3BQuarter to 30 Sep 2025: revenue $12.2B, net income $2.2BQuarter to 30 Sep 2025: revenue $12.2B, net income $2.2BQuarter to 31 Dec 2025: revenue $12.5B, net income $1.1BQuarter to 31 Dec 2025: revenue $12.5B, net income $1.1BQuarter to 31 Mar 2026: revenue $11.5B, net income $2.7BQuarter to 31 Mar 2026: revenue $11.5B, net income $2.7BQuarter to 30 Jun 2026: revenue $13.0B, net income $3.3BQuarter to 30 Jun 2026: revenue $13.0B, net income $3.3BQuarter to 30 Sep 2026: revenue $13.1B, net income $2.2BQuarter to 30 Sep 2026: revenue $13.1B, net income $2.2B
31 Dec 2021RevenueNet incomeNet losstallest bar $13.1B30 Sep 2026
See the numbers
Quarter toRevenueNet income
30 Sep 2026$13.1B$2.2B
30 Jun 2026$13.0B$3.3B
31 Mar 2026$11.5B$2.7B
31 Dec 2025$12.5B$1.1B
30 Sep 2025$12.2B$2.2B
30 Jun 2025$12.3B$1.3B
31 Mar 2025$11.2B$2.5B
31 Dec 2024$12.3B$72.0M
30 Sep 2024$11.9B$1.2B
30 Jun 2024$12.2B$1.7B
31 Mar 2024$11.9B-$11.9B
31 Dec 2023$11.5B$1.8B
30 Sep 2023$11.0B$1.9B
30 Jun 2023$11.2B$2.1B
31 Mar 2023$11.3B$2.3B
31 Dec 2022$11.4B$2.0B
30 Sep 2022$11.2B$1.6B
30 Jun 2022$11.9B$1.4B
31 Mar 2022$11.6B$1.3B
31 Dec 2021$12.0B$2.4B
Fundamentals, 12 months to 30 Sep 2026
MeasureLatestYear beforePeer median
RevenueSales over the last 12 months reported. $50.0B $48.0B
Revenue growthRevenue of the last 12 months compared with the 12 months before. +4.2% +11%
Net incomeProfit after all costs and taxes over the last 12 months reported. Negative is a loss. $9.2B $6.0B
EPS (diluted)Earnings per share: net income divided by the shares, counting options and convertibles. Left blank when the figures as filed do not fit today's share count (after a split). $4.51 $2.96
Gross marginWhat is left of each dollar of sales after the direct cost of making the product or service. 69.2% 69.5% 73.2%
Operating marginOperating income as a share of sales: profit from the business before interest and taxes. – – -25.0%
Net marginNet income as a share of sales: what the owners keep of each dollar sold. 18.5% 12.6% -18.2%
Return on equityNet income of the last 12 months divided by shareholders' equity (the average of the latest balance sheet and the one a year earlier): the profit made on the owners' money. 44.1% -58.8%
Free cash flowCash from operations minus capital spending over the last 12 months: cash the business produced. $9.3B $15.3B
CashCash, cash equivalents and short-term investments on the latest balance sheet. $12.6B $16.5B
DebtShort- and long-term borrowings on the latest balance sheet. Operating leases are not counted. $42.9B $49.0B
Net debtDebt minus cash. Negative means the company holds more cash than it owes (net cash). $30.3B $32.5B
Debt to equityDebt divided by shareholders' equity on the latest balance sheet: how much is borrowed for each dollar the owners have in the company. Blank when equity is negative. 1.8 0.0
Book value per shareShareholders' equity (assets minus liabilities) on the latest balance sheet divided by the shares outstanding. $11.45
P/EPrice to earnings: market cap divided by net income of the last 12 months. What investors pay for one dollar of yearly profit. Blank when the company made a loss. 13.0 19.3
P/SPrice to sales: market cap divided by revenue of the last 12 months. 2.4 5.0
EV/SalesEnterprise value (market cap plus debt minus cash) divided by revenue of the last 12 months. 3.0 5.0
P/BPrice to book: market cap divided by shareholders' equity on the latest balance sheet. Blank when equity is negative. 5.1 2.0
Dividend yieldDividends per share declared in the latest fiscal year divided by the share price. 4.2% 2.5%

Latest = 12 months to 30 Sep 2026; balance-sheet lines at its end. Peer median: companies in the same industry (SIC code), or the sector when the industry is small.

Peers nearest by market cap, its own industry first

CompanyMarket capP/EP/SRevenue growthNet margin
Bristol-Myers SquibbBMY (this company) $120.2B13.02.4+4.2%18.5%
Vertex PharmaceuticalsVRTX $130.6B32.810.1+10%30.7%
Regeneron PharmaceuticalsREGN $95.2B19.85.6+19%28.5%
PfizerPFE $156.2B38.72.5+1.3%6.3%
Abbott LaboratoriesABT $178.4B37.93.7+10%9.7%
Teva Pharmaceutical IndustriesTEVA $45.8B90.53.3-16%3.6%

Insider Buy/Sell Shares the company's insiders (directors, officers and owners of 10% or more) bought minus what they sold on the open market in the last 90 days, from their Form 4 filings.

-$678K

bought $0, sold $678K

Institutional holders The number of institutional investment managers (13F filers: funds, pensions, asset managers) reporting the stock, compared with the quarter before. 13F reports are public 45 days after quarter end and show long positions only.

+2.9%

2,535 13F filers vs 2,464

Institutional ownership Shares held by 13F filers at the latest quarter end, divided by the shares outstanding in the company's latest filing. Above 100% usually means a stale share count or double counting, and is marked.

80%

1.6B shares held by 13F filers (30 Sep 2026) of 2.0B outstanding (21 Oct 2026)

Short interest Shares sold short and not yet bought back, divided by the shares outstanding in the company's latest filing. From FINRA's latest short interest report: FINRA reports twice a month and publishes 7 business days after the settlement date. Above 100% means a stale share count, and is marked.

2.3%

46.8M shares sold short (30 Oct 2026) of 2.0B outstanding (21 Oct 2026)

Days to cover Short interest divided by the stock's average daily trading volume, as FINRA publishes it: how many days of normal trading it would take short sellers to buy back every share. Latest report.

4.2

46.8M shares sold short (30 Oct 2026) divided by the stock's average daily volume, as FINRA publishes it

Short interest change How the number of shares sold short changed between FINRA's two latest reports, about two weeks apart.

-6.2%

49.9M shares sold short in the report before, 46.8M on 30 Oct 2026

Short sale volume Share of the stock's latest daily volume on FINRA-reported off-exchange venues that was sold short. Market makers sell short routinely, so 40% to 50% is normal; compare it with the company's own 1-year average in the cell's details. A daily flow, not short interest.

40%

40% of off-exchange volume on 20 Nov 2026 was short sales; 1-year average 48%

Open jobs Job postings open on the company's own careers site today, where we track it. Blank when we do not track this company's careers site yet.

659

Tracked since 20 Nov 2026

Open jobs change How the number of open job postings changed over the last 30 days: total hiring demand, any job, any country. Shown only once we have tracked the company for 30 days.

–

Tracking started 20 Nov 2026; the change shows after 30 days.

Employees Total staff the company reported in its latest annual report (10-K), with the change from the year before when both years are reported.

–

No headcount in its annual reports in our data.

Visa hiring (foreign workers) Applications to hire foreign specialists on H-1B and E-3 visas certified by the Labor Department in the last 12 months, compared with the 12 months before. This is NOT total hiring: most hires need no visa. Open jobs shows total hiring where we track it.

+20%

298 vs 248 applications

Revenue growth Sales in the latest reported quarter compared with the same quarter a year earlier.

+6.9%

$13.1B vs $12.2B (quarter ended 30 Sep 2026)

Capital spending Money spent on buildings, machines and equipment in the latest quarter, compared with the same quarter a year earlier.

+7.5%

$344.0M vs $320.0M (quarter ended 30 Sep 2026)

Federal contracts Money the US government committed to the company in contracts and grants over the last 12 months.

–

No data for this company

Lobbying What the company reported spending on federal lobbying over the last four quarters.

$8.8M

4 quarters, $

Layoff notices Workers named in state WARN layoff notices over the last 12 months (employers must file them 60 days before a large layoff).

718

the 12 months before: 1,399

News (7d) Articles about the company published in the last 7 days, from our Google News collection (one search per company, every half hour). Blank when we do not collect news for this company.

88

88 articles in the last 7 days; its usual week has 8.5 (the median of the 26 weeks before).

News vs usual Articles in the last 7 days divided by the company's usual week: the median week of the 26 weeks before. Blank when the usual week has fewer than one article.

10×

88 articles in the last 7 days; its usual week has 8.5.

Unusual now sharp changes in the last 90 days, compared with its own past

  • Visa applications 41, 4.6× a year earlier
  • Layoff notice 265 workers
  • Short interest 45.9M, 1.5× a year earlier
  • New lobbying issue

Price $58.80 on 20 Nov 2026, +28% over 12 months (12-month range $45.94 to $68.09)

  • Sharp change
  • 8-K and other filings
  • WARN layoff notice
  • Lobbying filing
Insider net buying (open market). Insiders sold a net $2.5M in the last 12 months (the 12 months before: -$2.3M).
H-1B/E-3 applications certified. H-1B/E-3 applications certified: 298 published in the last 12 months, +21% on the 12 months before.
Revenue per quarter. Revenue $13.1B in the latest quarter, +6.9% on a year earlier.
Capital spending per quarter. Capital spending $344.0M in the latest quarter, +7.5% on a year earlier.
Institutional holders (13F filers). 2,535 13F filers reported holding it in the latest 13F quarter, +18% on a year earlier.
Lobbying spend. Lobbying spend: $8.8M published in the last 12 months, -8.9% on the 12 months before.
Workers in WARN layoff notices. Workers in WARN layoff notices: 828 published in the last 12 months, -36% on the 12 months before.

Every point sits on the day the fact became public (filing acceptance or publication), not the day it happened; prices through 20 Nov 2026. Hover or tap a marker for the fact; click it for the evidence or the source. No data here for: federal obligations.

See the numbers
Dated facts on the price chart (newest 100)
Became publicKindFact
12 Nov 2026Sharp changeH-1B/E-3 applications change: h-1B/E-3 applications change, 41 vs usual 12 in the same month of earlier years (2026-08-01..2026-08-31); 4.6x the same month a year earlier
21 Oct 2026Sharp changeLobbying on a new issue: lobbying on a new issue: DEF (2026-09-30)
1 Oct 2026WARN layoff noticeBristol Myers Squibb, 265 workers, Princeton, NJ
1 Oct 2026Sharp changeWARN layoff notice: wARN layoff notice (1 event(s) in 30 days, workers total 265)
1 Sep 2026Sharp changeShort interest spike: short interest spike, 45.9M vs usual 32.2M (2026-08-14); 1.5x the same period a year earlier
18 Aug 2026Sharp changeShort interest spike: short interest spike, 52.3M vs usual 31.9M (2026-07-31); 1.7x the same period a year earlier
11 Aug 2026Sharp changeWikipedia attention spike: wikipedia attention spike, 6,796 vs usual 2,177 (2026-08-03..2026-08-09); 2.3x the same week a year earlier
4 Aug 2026Lobbying filingnew lobbying registration (ADVANCED POLICY CONSULTING, LLC)
7 Jul 2026Sharp changeLobbying on a new issue: lobbying on a new issue: MED (2026-03-31)
29 Jun 2026Lobbying filingnew lobbying registration (ALEXANDER J. BECKLES, L.L.C.)
1 May 2026WARN layoff noticeBristol Myers Squibb, 206 workers, Lawrence Twp, NJ
1 May 2026Sharp changeWARN layoff notice: wARN layoff notice (1 event(s) in 30 days, workers total 206)
19 Apr 2026Lobbying filinglobbying engagement terminated (CROSSROADS STRATEGIES, LLC)
1 Mar 2026WARN layoff noticeBristol Myers Squibb, 247 workers, Lawrence Twp, NJ
1 Mar 2026Sharp changeWARN layoff notice: wARN layoff notice (1 event(s) in 30 days, workers total 247)
25 Feb 2026Lobbying filingnew lobbying registration (CAPITOL COUNSEL LLC)
24 Feb 2026Lobbying filingnew lobbying registration (MARSHALL & POPP, LLC)
23 Feb 2026Lobbying filingnew lobbying registration (AVENUE SOLUTIONS)
18 Feb 2026Lobbying filingnew lobbying registration (W STRATEGIES, LLC)
1 Dec 2025WARN layoff noticeBristol Myers Squibb (BMS), 110 workers, Lawrence Twp, NJ
1 Dec 2025Sharp changeWARN layoff notice: wARN layoff notice (1 event(s) in 30 days, workers total 110)
6 Oct 2025Lobbying filingnew lobbying registration (MILLER STRATEGIES, LLC)
1 Oct 2025WARN layoff noticeBristol Myers Squibb (BMS), 282 workers, Lawrence Twp, NJ
1 Oct 2025Sharp changeWARN layoff notice: wARN layoff notice (1 event(s) in 30 days, workers total 282)
2 Sep 2025Sharp changeH-1B/E-3 applications change: h-1B/E-3 applications change, 44 vs usual 15 in the same month of earlier years (2025-06-01..2025-06-30); 2.9x the same month a year earlier
28 Jul 2025Lobbying filingnew lobbying registration (THE MCMANUS GROUP)
25 Jul 20258-K and other filingsDirector or officer change
25 Jul 2025Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
1 Jul 2025WARN layoff noticeBristol Myers Squibb (BMS), 68 workers, Lawrence Twp, NJ
1 Jul 2025Sharp changeWARN layoff notice: wARN layoff notice (1 event(s) in 30 days, workers total 68)
1 Jun 2025WARN layoff noticeBristol Myers Squibb (BMS), 516 workers, Lawrence Twp, NJ
3 May 2025WARN layoff noticeBristol Myers Squibb, 133 workers, Libertyville, IL
3 May 2025Sharp changeWARN layoff notice: wARN layoff notice (1 event(s) in 30 days, workers total 133)
17 Mar 2025Lobbying filinglobbying engagement terminated (TIBER CREEK HEALTH STRATEGIES, INC.)
17 Mar 2025Lobbying filinglobbying engagement terminated (TIBER CREEK GROUP)
1 Mar 2025WARN layoff noticeBristol Myers Squibb (BMS), 290 workers, Lawrence Twp, NJ
1 Mar 2025Sharp changeWARN layoff notice: wARN layoff notice (1 event(s) in 30 days, workers total 290)
18 Feb 20258-K and other filingsDirector or officer change
18 Feb 2025Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
19 Nov 2024Sharp changeMany funds opening a new position: many funds opening a new position, 223 vs usual 81.50 (2024-09-30); 3.0x the same period a year earlier
1 Oct 2024WARN layoff noticeBristol Myers Squibb, 79 workers, Lawrenceville, NJ
1 Oct 2024Sharp changeWARN layoff notice: wARN layoff notice (1 event(s) in 30 days, workers total 79)
17 Sep 2024Sharp changeH-1B/E-3 applications change: h-1B/E-3 applications change, 48 vs usual 21.50 in the same month of earlier years (2024-05-01..2024-05-31); 1.3x the same month a year earlier
20 Aug 2024Sharp changeMany funds opening a new position: many funds opening a new position, 134 vs usual 81.50 (2024-06-30); 1.7x the same period a year earlier
1 Aug 2024WARN layoff noticeBristol Myers Squibb, 117 workers, Lawrenceville, NJ
1 Aug 2024Sharp changeWARN layoff notice: wARN layoff notice (1 event(s) in 30 days, workers total 117)
22 Jul 2024Lobbying filinglobbying engagement terminated (AVENUE SOLUTIONS)
22 Jul 2024Lobbying filinglobbying engagement terminated (W STRATEGIES, LLC)
18 Jun 20248-K and other filingsDirector or officer change
18 Jun 2024Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
1 Jun 2024WARN layoff noticeBristol Myers Squibb, 863 workers, Lawrenceville, NJ
1 Jun 2024Sharp changeWARN layoff notice: wARN layoff notice (1 event(s) in 30 days, workers total 863)
24 May 2024Lobbying filingnew lobbying registration (TODD STRATEGY GROUP)
21 May 2024Sharp changeMany funds opening a new position: many funds opening a new position, 125 vs usual 81.50 (2024-03-31); 1.7x the same period a year earlier
1 Apr 2024WARN layoff noticeBristol Myers Squibb, 75 workers, Lawrenceville, NJ
1 Apr 2024Sharp changeWARN layoff notice: wARN layoff notice (1 event(s) in 30 days, workers total 75)
18 Mar 20248-K and other filingsDirector or officer change
1 Mar 2024WARN layoff noticeBristol Myers Squibb (BMS), 290 workers, Lawrence Twp, NJ
1 Mar 2024Sharp changeWARN layoff notice: wARN layoff notice (1 event(s) in 30 days, workers total 290)
15 Feb 20248-K and other filingsDirector or officer change
15 Feb 2024Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
3 Oct 2023Sharp changeShort interest spike: short interest spike, 37.0M vs usual 20.8M (2023-09-15); 1.6x the same period a year earlier
19 Sep 2023Sharp changeShort interest spike: short interest spike, 43.8M vs usual 20.8M (2023-08-31); 1.9x the same period a year earlier
1 Sep 2023WARN layoff noticeBristol Myers Squibb, 108 workers, Lawrence, Princeton, Berkeley Heights, Pennington, New Brunswick, NJ
1 Sep 2023Sharp changeWARN layoff notice: wARN layoff notice (1 event(s) in 30 days, workers total 108)
29 Aug 2023Sharp changeH-1B/E-3 applications change: h-1B/E-3 applications change, 36 vs usual 21 in the same month of earlier years (2023-05-01..2023-05-31); 1.6x the same month a year earlier
29 Aug 2023Sharp changeWikipedia attention spike: wikipedia attention spike, 5,070 vs usual 2,960 (2023-08-21..2023-08-27); 2.0x the same week a year earlier
29 Aug 2023Sharp changeShort interest spike: short interest spike, 53.5M vs usual 20.8M (2023-08-15); 2.2x the same period a year earlier
18 Aug 2023Lobbying filingnew lobbying registration (AVENUE SOLUTIONS)
4 May 20238-K and other filingsDirector or officer change
1 May 2023WARN layoff noticeBristol Myers Squibb, 48 workers, Princeton, NJ
1 May 2023Sharp changeWARN layoff notice: wARN layoff notice (1 event(s) in 30 days, workers total 48)
26 Apr 20238-K and other filingsDirector or officer change
31 Jan 20238-K and other filingsDirector or officer change
31 Jan 2023Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
15 Jun 20228-K and other filingsDirector or officer change
15 Jun 2022Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
17 May 2022Sharp changeMany funds opening a new position: many funds opening a new position, 154 vs usual 111 (2022-03-31); 1.5x the same period a year earlier
17 May 2022Sharp changeShort interest spike: short interest spike, 35.4M vs usual 21.0M (2022-04-29); 1.7x the same period a year earlier
3 May 2022Sharp changeShort interest spike: short interest spike, 42.2M vs usual 20.9M (2022-04-14); 2.2x the same period a year earlier
12 Apr 2022Sharp changeShort interest spike: short interest spike, 47.3M vs usual 20.9M (2022-03-31); 2.8x the same period a year earlier
29 Mar 2022Sharp changeShort interest spike: short interest spike, 53.7M vs usual 20.9M (2022-03-15); 2.1x the same period a year earlier
17 Mar 20228-K and other filingsDirector or officer change
17 Mar 2022Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
15 Mar 2022Sharp changeShort interest spike: short interest spike, 63.2M vs usual 20.8M (2022-02-28); 2.2x the same period a year earlier
1 Mar 2022Sharp changeShort interest spike: short interest spike, 70.9M vs usual 20.8M (2022-02-15); 3.4x the same period a year earlier
24 Feb 2022Lobbying filingnew lobbying registration (FEDERAL STREET STRATEGIES, LLC)
20 Jan 2022Lobbying filinglobbying engagement terminated (THE NICKLES GROUP, LLC)
20 Jan 2022Lobbying filingnew lobbying registration (W STRATEGIES, LLC)
19 Jan 2022Lobbying filinglobbying engagement terminated (PUBLIC STRATEGIES WASHINGTON, INC.)
Insider net buying (open market)
Month from 1 Nov 2021: -$2.9M published
Month from 1 Dec 2021: -$1.2M published
Month from 1 Mar 2022: -$11.5M published
Month from 1 Jun 2022: -$7.1M published
Month from 1 Sep 2022: -$16.7M published
Month from 1 Nov 2022: -$4.9M published
Month from 1 Feb 2023: -$18.8M published
Month from 1 May 2023: -$3.4M published
Month from 1 Aug 2023: -$1.1M published
Month from 1 Nov 2023: $423K published
Month from 1 Dec 2023: $250K published
Month from 1 Nov 2024: $61K published
Month from 1 Feb 2025: $210K published
Month from 1 Apr 2025: $202K published
Month from 1 May 2025: -$4K published
Month from 1 Aug 2025: -$17K published
Month from 1 Sep 2025: -$2.7M published
Month from 1 Apr 2026: -$1.9M published
Month from 1 Aug 2026: -$34K published
Month from 1 Sep 2026: -$403K published
Month from 1 Nov 2026: -$241K published
H-1B/E-3 applications certified
Quarter from 1 Jan 2022: 43 published
Quarter from 1 Apr 2022: 55 published
Quarter from 1 Jul 2022: 49 published
Quarter from 1 Oct 2022: 35 published
Quarter from 1 Jan 2023: 33 published
Quarter from 1 Apr 2023: 48 published
Quarter from 1 Jul 2023: 83 published
Quarter from 1 Oct 2023: 60 published
Quarter from 1 Jan 2024: 66 published
Quarter from 1 Apr 2024: 67 published
Quarter from 1 Jul 2024: 80 published
Quarter from 1 Oct 2024: 57 published
Quarter from 1 Jan 2025: 38 published
Quarter from 1 Apr 2025: 44 published
Quarter from 1 Jul 2025: 132 published
Quarter from 1 Oct 2025: 33 published
Quarter from 1 Jan 2026: 35 published
Quarter from 1 Apr 2026: 26 published
Quarter from 1 Jul 2026: 124 published
Quarter from 1 Oct 2026: 113 published
Revenue per quarter
Quarter ended 31 Dec 2021: $12.0B, +8.3% on a year earlier; public on 10 Feb 2022
Quarter ended 31 Mar 2022: $11.6B, +5.2% on a year earlier; public on 30 Apr 2022
Quarter ended 30 Jun 2022: $11.9B, +1.6% on a year earlier; public on 28 Jul 2022
Quarter ended 30 Sep 2022: $11.2B, -3.5% on a year earlier; public on 27 Oct 2022
Quarter ended 31 Dec 2022: $11.4B, -4.8% on a year earlier; public on 15 Feb 2023
Quarter ended 31 Mar 2023: $11.3B, -2.7% on a year earlier; public on 28 Apr 2023
Quarter ended 30 Jun 2023: $11.2B, -5.6% on a year earlier; public on 28 Jul 2023
Quarter ended 30 Sep 2023: $11.0B, -2.2% on a year earlier; public on 27 Oct 2023
Quarter ended 31 Dec 2023: $11.5B, +0.6% on a year earlier; public on 14 Feb 2024
Quarter ended 31 Mar 2024: $11.9B, +4.7% on a year earlier; public on 26 Apr 2024
Quarter ended 30 Jun 2024: $12.2B, +8.7% on a year earlier; public on 27 Jul 2024
Quarter ended 30 Sep 2024: $11.9B, +8.4% on a year earlier; public on 1 Nov 2024
Quarter ended 31 Dec 2024: $12.3B, +7.5% on a year earlier; public on 13 Feb 2025
Quarter ended 31 Mar 2025: $11.2B, -5.6% on a year earlier; public on 25 Apr 2025
Quarter ended 30 Jun 2025: $12.3B, +0.6% on a year earlier; public on 1 Aug 2025
Quarter ended 30 Sep 2025: $12.2B, +2.8% on a year earlier; public on 31 Oct 2025
Quarter ended 31 Dec 2025: $12.5B, +1.3% on a year earlier; public on 12 Feb 2026
Quarter ended 31 Mar 2026: $11.5B, +2.6% on a year earlier; public on 1 May 2026
Quarter ended 30 Jun 2026: $13.0B, +5.7% on a year earlier; public on 31 Jul 2026
Quarter ended 30 Sep 2026: $13.1B, +6.9% on a year earlier; public on 30 Oct 2026
Capital spending per quarter
Quarter ended 31 Dec 2021: $320.0M, +13% on a year earlier; public on 10 Feb 2022
Quarter ended 31 Mar 2022: $253.0M, +46% on a year earlier; public on 30 Apr 2022
Quarter ended 30 Jun 2022: $272.0M, +30% on a year earlier; public on 28 Jul 2022
Quarter ended 30 Sep 2022: $247.0M, -8.5% on a year earlier; public on 27 Oct 2022
Quarter ended 31 Dec 2022: $346.0M, +8.1% on a year earlier; public on 15 Feb 2023
Quarter ended 31 Mar 2023: $278.0M, +9.9% on a year earlier; public on 28 Apr 2023
Quarter ended 30 Jun 2023: $259.0M, -4.8% on a year earlier; public on 28 Jul 2023
Quarter ended 30 Sep 2023: $342.0M, +38% on a year earlier; public on 27 Oct 2023
Quarter ended 31 Dec 2023: $330.0M, -4.6% on a year earlier; public on 14 Feb 2024
Quarter ended 31 Mar 2024: $284.0M, +2.2% on a year earlier; public on 26 Apr 2024
Quarter ended 30 Jun 2024: $262.0M, +1.2% on a year earlier; public on 27 Jul 2024
Quarter ended 30 Sep 2024: $324.0M, -5.3% on a year earlier; public on 1 Nov 2024
Quarter ended 31 Dec 2024: $378.0M, +15% on a year earlier; public on 13 Feb 2025
Quarter ended 31 Mar 2025: $260.0M, -8.5% on a year earlier; public on 25 Apr 2025
Quarter ended 30 Jun 2025: $361.0M, +38% on a year earlier; public on 1 Aug 2025
Quarter ended 30 Sep 2025: $320.0M, -1.2% on a year earlier; public on 31 Oct 2025
Quarter ended 31 Dec 2025: $370.0M, -2.1% on a year earlier; public on 12 Feb 2026
Quarter ended 31 Mar 2026: $347.0M, +33% on a year earlier; public on 1 May 2026
Quarter ended 30 Jun 2026: $305.0M, -16% on a year earlier; public on 31 Jul 2026
Quarter ended 30 Sep 2026: $344.0M, +7.5% on a year earlier; public on 30 Oct 2026
Institutional holders (13F filers)
31 Dec 2021 report: 2,162; public on 14 Feb 2022
31 Mar 2022 report: 2,338; public on 16 May 2022
30 Jun 2022 report: 2,372; public on 15 Aug 2022
30 Sep 2022 report: 2,263; public on 14 Nov 2022
31 Dec 2022 report: 2,377; public on 14 Feb 2023
31 Mar 2023 report: 2,363; public on 15 May 2023
30 Jun 2023 report: 2,269; public on 14 Aug 2023
30 Sep 2023 report: 2,187; public on 14 Nov 2023
31 Dec 2023 report: 2,171; public on 14 Feb 2024
31 Mar 2024 report: 2,196; public on 15 May 2024
30 Jun 2024 report: 2,018; public on 14 Aug 2024
30 Sep 2024 report: 2,124; public on 14 Nov 2024
31 Dec 2024 report: 2,326; public on 14 Feb 2025
31 Mar 2025 report: 2,349; public on 15 May 2025
30 Jun 2025 report: 2,178; public on 14 Aug 2025
30 Sep 2025 report: 2,140; public on 14 Nov 2025
31 Dec 2025 report: 2,330; public on 17 Feb 2026
31 Mar 2026 report: 2,443; public on 15 May 2026
30 Jun 2026 report: 2,464; public on 14 Aug 2026
30 Sep 2026 report: 2,535; public on 16 Nov 2026
Lobbying spend
Quarter from 1 Jan 2022: $760K published
Quarter from 1 Apr 2022: $2.4M published
Quarter from 1 Jul 2022: $1.7M published
Quarter from 1 Oct 2022: $950K published
Quarter from 1 Jan 2023: $750K published
Quarter from 1 Apr 2023: $2.5M published
Quarter from 1 Jul 2023: $2.3M published
Quarter from 1 Oct 2023: $2.3M published
Quarter from 1 Jan 2024: $2.2M published
Quarter from 1 Apr 2024: $720K published
Quarter from 1 Jul 2024: $760K published
Quarter from 1 Oct 2024: $3.3M published
Quarter from 1 Jan 2025: $810K published
Quarter from 1 Apr 2025: $870K published
Quarter from 1 Jul 2025: $4.8M published
Quarter from 1 Oct 2025: $3.2M published
Quarter from 1 Jan 2026: $1.2M published
Quarter from 1 Jul 2026: $4.5M published
Quarter from 1 Oct 2026: $3.0M published
Workers in WARN layoff notices
Month from 1 May 2023: 48 published
Month from 1 Sep 2023: 108 published
Month from 1 Mar 2024: 290 published
Month from 1 Apr 2024: 75 published
Month from 1 Jun 2024: 863 published
Month from 1 Aug 2024: 117 published
Month from 1 Oct 2024: 79 published
Month from 1 Mar 2025: 290 published
Month from 1 May 2025: 649 published
Month from 1 Jul 2025: 68 published
Month from 1 Oct 2025: 282 published
Month from 1 Dec 2025: 110 published
Month from 1 Mar 2026: 247 published
Month from 1 May 2026: 206 published
Month from 1 Oct 2026: 265 published

What is unusual now

  • Made public in the last 90 days: it had 41 H-1B/E-3 visa applications certified in August 2026, 4.6× the same month last year; it also filed a WARN layoff notice covering 265 workers within 30 days (Princeton, NJ). 4 sharp changes in all. Two or more unrelated kinds of activity agreed on 18 Aug 2026.
  • Wikipedia attention spike: drew 6,796 Wikipedia page views in the week of 3 Aug 2026, 2.3× the same week last year Public on 11 Aug 2026.
  • H-1B/E-3 applications change: had 41 H-1B/E-3 visa applications certified in August 2026, 4.6× the same month last year Public on 12 Nov 2026.
  • Short interest spike: had 52.3M shares sold short in the 31 Jul 2026 report, 1.7× the same report last year Public on 12 Aug 2026.

Latest records

The names and amounts behind the totals, newest first

Last 90 days: 3 sales, $678K; no purchases. Open-market trades by officers, directors and 10% owners.

FiledInsiderTradeSharesPriceValueSource
6 Nov 2026Julia A HallerDirectorSell3,800$63.31$241KForm 4
10 Sep 2026Cristian MassacesiEVP,Chief Med Offr,Head of DevSell6,249$64.57$403KForm 4
26 Aug 2026Phil M HolzerSVP and ControllerSell500$67.50$34KForm 4
2 Apr 2026David Elkins VEVP, Chief Financial OfficerSell30,000$61.67$1.9MForm 4
3 Sep 2025David Elkins VEVP, Chief Financial OfficerSell56,000$47.33$2.7MForm 4
5 Aug 2025Bartie Wendy ShortEVP, Corporate AffairsSellafter exercising options378$44.23$17KForm 4
13 May 2025Benjamin HickeyPresident, RayzeBio Org.Sell97$38.01$4KForm 4
29 Apr 2025Samit HirawatEVP,Chief Med.Offr.,Drug Dev.Buy4,250$47.58$202KForm 4

2,535 institutions reported shares at the end of Q3 2026, 80% of the shares outstanding; 191 opened a position, 127 sold out. From 13F reports.

InstitutionShares% of companyValueChange vs Q2 2026
BlackRock, Inc.173.7M8.50%$10.8B-6.7M-3.7%
Vanguard Capital Management LLC133.7M6.54%$8.3B+347K+0.3%
State Street Corp103.3M5.06%$6.4B+927K+0.9%
Charles Schwab Investment Management Inc72.5M3.54%$4.5B+4.9M+7.2%
JPMorgan Chase & Co60.2M2.95%$3.8B-11.5M-16%
Geode Capital Management, LLC50.6M2.48%$3.2B-5.8M-10%
Vanguard Portfolio Management LLC47.1M2.30%$2.9B+189K+0.4%
Bank of America Corp40.3M1.97%$2.5B+6.2M+18%
Morgan Stanley28.4M1.39%$1.8B-629K-2.2%
FMR LLC (Fidelity)28.3M1.39%$1.8B+12.0M+74%

Company events

All 53 company events

Nothing in 12 months; the latest was filed 25 Jul 2025. Results releases and routine reports are left out.

FiledWhat happenedSource
25 Jul 2025Director or officer change8-K
18 Feb 2025Director or officer change8-K
18 Jun 2024Director or officer change8-K
18 Mar 2024Director or officer change8-K
15 Feb 2024Director or officer change8-K
4 May 2023Director or officer changeSame filing: shareholder vote results8-K
26 Apr 2023Director or officer change8-K
31 Jan 2023Director or officer change8-K

659 open postings; careers site tracked since 20 Nov 2026. Most in Research & science 9%, Marketing & communications 4%, ML / AI 4%, Manufacturing & production 3%.

PostedJobLocation
20 Nov 2026or earlierClinical Trial MonitorNot stated
20 Nov 2026or earlierIO Account ExecutiveSales & business developmentZhengzhou - CN
20 Nov 2026or earlierManager, Cell Therapy SpecialistField - Japan
20 Nov 2026or earlierTherapeutic Area Specialist, Cardiovascular / Pharmareferent (m/w/d) - Gebiet 10202: Berlin & SüdbrandenburgBerlin - DE
20 Nov 2026or earlierExecutive Director U.S. and Above Markets Compliance OfficerLegal, policy & compliancePrinceton - NJ - US
20 Nov 2026or earlierSenior Therapeutic Area Specialist, Oncology (San Francisco, CA)San Francisco - CA - US
20 Nov 2026or earlierAssociate Director, Real World Data StrategyField - United States
20 Nov 2026or earlierSr Medical Director Clinical Development - Radiopharmaceuticals HCC and GI cancersRemote - United States - US

Reported lobbying spend: $3.0M in Q3 2026, $3.2M in Q2 2026. Rows are lobbying firms hired or let go; amounts are reported per quarter, not per firm here.

DateChangeLobbying firmIssueSource
1 Jul 2026NewAdvanced Policy Consulting, LLCfor Bristol-Myers Squibb CompanyEducation regarding the value of biopharmaceutical innovation and related issues.Health issuesFiling
19 Feb 2026NewMarshall & Popp, LLCfor Bristol-Myers Squibb CompanyIssues related to pharmaceutical manufacuring. Drug pricing. Trade and tariffs.Pharmacy, TradeFiling
1 Feb 2026NewAlexander J. Beckles, L.L.C.for Bristol Myers SquibbLife sciences innovation; access to medicines.Health issuesFiling
1 Feb 2026NewCapitol Counsel LLCfor Bristol-Myers SquibbIssues regarding approved and pipeline products, and related policy.Health issues, MED, Medicare/MedicaidFiling
1 Feb 2026NewW Strategies, LLCfor Bristol-Myers Squibb CompanyEducation about the value of biopharmaceutical innovation and related issues.Health issuesFiling
1 Jan 2026EndedCrossroads Strategies, LLCfor Bristol-Myers SquibbNot statedFiling
1 Jan 2026NewAvenue Solutionsfor Bristol-Myers Squibb CompanyIssues related to prescription drugs.Health issues, Medicare/MedicaidFiling
1 Sep 2025NewMiller Strategies, LLCfor Bristol-Myers Squibb CompanyIssues related to biosimilars reimbursement, supply chain and Medicare/Medicaid payment reform.Health issues, Medicare/MedicaidFiling

Layoff notices

All 22 layoff notices

3 notices in 12 months covering 718 workers. State WARN notices.

NoticeSiteWorkersJobs endSource
1 Sep 2026Bristol Myers SquibbPrinceton, NJ26517 Dec 2026Notice
1 Apr 2026Bristol Myers SquibbLawrence Twp, NJ20616 Jul 2026Notice
1 Feb 2026Bristol Myers SquibbLawrence Twp, NJ24721 May 2026Notice
1 Nov 2025Bristol Myers Squibb (BMS)Lawrence Twp, NJ11012 Feb 2026Notice
1 Sep 2025Bristol Myers Squibb (BMS)Lawrence Twp, NJ28211 Dec 2025Notice
1 Jun 2025Bristol Myers Squibb (BMS)Lawrence Twp, NJ6825 Sep 2025Notice
2 May 2025Bristol Myers SquibbLake County, IL1331 Jul 2025layoffNotice
1 May 2025Bristol Myers Squibb (BMS)Lawrence Twp, NJ5169 May 2025Notice

The 5 newest of 826 articles that name the company.

Timeline

Several things at once

Two or more unrelated kinds of records unusual within 30 days

18 Aug 2026confirmed

Confirmed across sources Attention and Hiring and Layoff notices and Lobbying and Short interest and volume

Bristol-Myers Squibb (BMY): drew 6,796 Wikipedia page views in the week of 3 Aug 2026, 2.3× the same week last year; it also had 52.3M shares sold short in the 31 Jul 2026 report, 1.7× the same report last year; it also filed a WARN layoff notice covering 265 workers within 30 days (Princeton, NJ); it also lobbying on a new issue; and it had 41 H-1B/E-3 visa applications certified in August 2026, 4.6× the same month last year. Five unrelated kinds of activity within 93 days.

  • Attention: Wikipedia attention spike, became public on 11 Aug 2026
  • Short interest and volume: Short interest spike, became public on 12 Aug 2026
  • Short interest and volume: Short interest spike, became public on 26 Aug 2026
  • Layoff notices: WARN layoff notice, became public on 1 Oct 2026
  • Lobbying: Lobbying on a new issue, became public on 21 Oct 2026
  • Hiring: H-1B/E-3 applications change, became public on 12 Nov 2026
2026-02-02: 2,6462026-02-09: 2,1912026-02-16: 1,9902026-02-23: 2,2052026-03-02: 2,1142026-03-09: 2,2202026-03-16: 2,0742026-03-23: 2,1142026-03-30: 2,0842026-04-06: 2,1062026-04-13: 2,2472026-04-20: 2,1632026-04-27: 2,4562026-05-04: 2,2942026-05-11: 2,6792026-05-18: 2,4152026-05-25: 2,0712026-06-01: 2,1222026-06-08: 2,2172026-06-15: 1,8382026-06-22: 1,8172026-06-29: 1,9972026-07-06: 2,0812026-07-13: 2,2872026-07-20: 2,4832026-07-27: 2,8902026-08-03: 6,796
The week of 3 Aug 2026 against the 26 weeks before it. this weekearliernormal: 2,177
See the evidence (6 changes)

Attention: Wikipedia attention spike became public on 11 Aug 2026

Bristol-Myers Squibb drew 6,796 Wikipedia page views in the week of 3 Aug 2026, 2.3× the same week last year.

This period
6,796 (the week of 3 Aug 2026)
Normal week (median of 26 earlier)
2,177
Typical spread (median absolute deviation)
104
How far from its usual level
+21.2
Same week last year
2,895
History used
2,777 days
2026-02-02: 2,6462026-02-09: 2,1912026-02-16: 1,9902026-02-23: 2,2052026-03-02: 2,1142026-03-09: 2,2202026-03-16: 2,0742026-03-23: 2,1142026-03-30: 2,0842026-04-06: 2,1062026-04-13: 2,2472026-04-20: 2,1632026-04-27: 2,4562026-05-04: 2,2942026-05-11: 2,6792026-05-18: 2,4152026-05-25: 2,0712026-06-01: 2,1222026-06-08: 2,2172026-06-15: 1,8382026-06-22: 1,8172026-06-29: 1,9972026-07-06: 2,0812026-07-13: 2,2872026-07-20: 2,4832026-07-27: 2,8902026-08-03: 6,796
the week of 3 Aug 202626 earlier weeksnormal: 2,177

Fires when the period is at least 5.0 robust standard deviations above the company's own median, with 20+ earlier periods, 365+ days of history and a value of at least 5,000.

Check it at the source: Wikimedia page view statistics.

Short interest and volume: Short interest spike became public on 12 Aug 2026

Bristol-Myers Squibb had 52.3M shares sold short in the 31 Jul 2026 report, 1.7× the same report last year.

This period
52.3M (the 31 Jul 2026 report)
Normal report (median of 24 earlier)
31.9M
Typical spread (median absolute deviation)
2.0M
How far from its usual level
+6.4
Same report last year
30.9M
History used
3,136 days
2025-07-31: 30.9M2025-08-15: 29.7M2025-08-29: 31.2M2025-09-15: 29.5M2025-09-30: 26.3M2025-10-15: 30.4M2025-10-31: 32.1M2025-11-14: 31.7M2025-11-28: 33.9M2025-12-15: 35.4M2025-12-31: 36.6M2026-01-15: 37.0M2026-01-30: 29.9M2026-02-13: 31.7M2026-02-27: 33.4M2026-03-13: 29.9M2026-03-31: 31.5M2026-04-15: 32.4M2026-04-30: 31.3M2026-05-15: 36.7M2026-05-29: 38.5M2026-06-15: 39.6M2026-06-30: 40.5M2026-07-15: 44.9M2026-07-31: 52.3M
the 31 Jul 2026 report24 earlier reportsnormal: 31.9M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 26 Aug 2026

Bristol-Myers Squibb had 45.9M shares sold short in the 14 Aug 2026 report, 1.5× the same report last year.

This period
45.9M (the 14 Aug 2026 report)
Normal report (median of 24 earlier)
32.2M
Typical spread (median absolute deviation)
2.5M
How far from its usual level
+3.7
Same report last year
29.7M
History used
3,150 days
2025-08-15: 29.7M2025-08-29: 31.2M2025-09-15: 29.5M2025-09-30: 26.3M2025-10-15: 30.4M2025-10-31: 32.1M2025-11-14: 31.7M2025-11-28: 33.9M2025-12-15: 35.4M2025-12-31: 36.6M2026-01-15: 37.0M2026-01-30: 29.9M2026-02-13: 31.7M2026-02-27: 33.4M2026-03-13: 29.9M2026-03-31: 31.5M2026-04-15: 32.4M2026-04-30: 31.3M2026-05-15: 36.7M2026-05-29: 38.5M2026-06-15: 39.6M2026-06-30: 40.5M2026-07-15: 44.9M2026-07-31: 52.3M2026-08-14: 45.9M
the 14 Aug 2026 report24 earlier reportsnormal: 32.2M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Layoff notices: WARN layoff notice became public on 1 Oct 2026

Bristol-Myers Squibb filed a WARN layoff notice covering 265 workers within 30 days (Princeton, NJ).

Notices in the window
1
Workers named
265
Window
1 Sep 2026 to 1 Oct 2026

Fires on a WARN notice after 30 days without one; notices within 30 days are summed.

Lobbying: Lobbying on a new issue became public on 21 Oct 2026

Bristol-Myers Squibb lobbying on a new issue.

New
['DEF']
Rule
only points whose every posting (and value revision) is at or before as_of
Field
issue_codes
Metric
lobbying.filings_count
Point id
4288795

Hiring: H-1B/E-3 applications change became public on 12 Nov 2026

Bristol-Myers Squibb had 41 H-1B/E-3 visa applications certified in August 2026, 4.6× the same month last year.

This period
41 (August 2026)
Normal month (median of 5 earlier)
12
Typical spread (median absolute deviation)
3
How far from its usual level
+6.5
Same month last year
9
History used
2,520 days
2021-08-01: 182022-08-01: 102023-08-01: 202024-08-01: 122025-08-01: 92026-08-01: 41
August 20265 earlier monthsnormal: 12

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 9+ earlier periods, 365+ days of history and a value of at least 20.

Check it at the source: DOL foreign labor disclosure data.

Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

1 Oct 2025confirmed

Confirmed across sources Hiring and Layoff notices

Bristol-Myers Squibb (BMY): had 44 H-1B/E-3 visa applications certified in June 2025, 2.9× the same month last year, while it filed a WARN layoff notice covering 282 workers within 30 days (Lawrence Twp, NJ). Two unrelated kinds of activity within 28 days.

  • Hiring: H-1B/E-3 applications change, became public on 31 Aug 2025
  • Layoff notices: WARN layoff notice, became public on 1 Oct 2025
2020-06-01: 102021-06-01: 232022-06-01: 122023-06-01: 182024-06-01: 152025-06-01: 44
June 2025 against the 5 months before it. this monthearliernormal: 15
See the evidence (2 changes)

Hiring: H-1B/E-3 applications change became public on 31 Aug 2025

Bristol-Myers Squibb had 44 H-1B/E-3 visa applications certified in June 2025, 2.9× the same month last year.

This period
44 (June 2025)
Normal month (median of 5 earlier)
15
Typical spread (median absolute deviation)
3
How far from its usual level
+6.5
Same month last year
15
History used
2,093 days
2020-06-01: 102021-06-01: 232022-06-01: 122023-06-01: 182024-06-01: 152025-06-01: 44
June 20255 earlier monthsnormal: 15

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 9+ earlier periods, 365+ days of history and a value of at least 20.

Check it at the source: DOL foreign labor disclosure data.

Layoff notices: WARN layoff notice became public on 1 Oct 2025

Bristol-Myers Squibb filed a WARN layoff notice covering 282 workers within 30 days (Lawrence Twp, NJ).

Notices in the window
1
Workers named
282
Window
1 Sep 2025 to 1 Oct 2025

Fires on a WARN notice after 30 days without one; notices within 30 days are summed.

Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

20 Aug 2024confirmed

Confirmed across sources Hiring and Institutional holdings and Layoff notices

Bristol-Myers Squibb (BMY): saw 134 13F filers open a new position in the quarter ended 30 Jun 2024, 1.7× the same quarter last year; it also had 48 H-1B/E-3 visa applications certified in May 2024, 1.3× the same month last year; and it filed a WARN layoff notice covering 79 workers within 30 days (Lawrenceville, NJ). Three unrelated kinds of activity within 61 days.

  • Layoff notices: WARN layoff notice, became public on 1 Aug 2024
  • Institutional holdings: Many funds opening a new position, became public on 14 Aug 2024
  • Hiring: H-1B/E-3 applications change, became public on 13 Sep 2024
  • Layoff notices: WARN layoff notice, became public on 1 Oct 2024
2022-06-30: 1182022-09-30: 732022-12-31: 1182023-03-31: 742023-06-30: 772023-09-30: 742023-12-31: 862024-03-31: 1252024-06-30: 134
The quarter ended 30 Jun 2024 against the 8 quarters before it. this quarterearliernormal: 81.5
See the evidence (4 changes)

Layoff notices: WARN layoff notice became public on 1 Aug 2024

Bristol-Myers Squibb filed a WARN layoff notice covering 117 workers within 30 days (Lawrenceville, NJ).

Notices in the window
1
Workers named
117
Window
2 Jul 2024 to 1 Aug 2024

Fires on a WARN notice after 30 days without one; notices within 30 days are summed.

Institutional holdings: Many funds opening a new position became public on 14 Aug 2024

Bristol-Myers Squibb saw 134 13F filers open a new position in the quarter ended 30 Jun 2024, 1.7× the same quarter last year.

This period
134 (the quarter ended 30 Jun 2024)
Normal quarter (median of 8 earlier)
81.5
Typical spread (median absolute deviation)
8
How far from its usual level
+4.4
Same quarter last year
77
History used
3,926 days
2022-06-30: 1182022-09-30: 732022-12-31: 1182023-03-31: 742023-06-30: 772023-09-30: 742023-12-31: 862024-03-31: 1252024-06-30: 134
the quarter ended 30 Jun 20248 earlier quartersnormal: 81.5

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

Check it at the source: SEC Form 13F data sets.

Hiring: H-1B/E-3 applications change became public on 13 Sep 2024

Bristol-Myers Squibb had 48 H-1B/E-3 visa applications certified in May 2024, 1.3× the same month last year.

This period
48 (May 2024)
Normal month (median of 4 earlier)
21.5
Typical spread (median absolute deviation)
0.5
How far from its usual level
+8.8
Same month last year
36
History used
1,698 days
2020-05-01: 212021-05-01: 212022-05-01: 222023-05-01: 362024-05-01: 48
May 20244 earlier monthsnormal: 21.5

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 9+ earlier periods, 365+ days of history and a value of at least 20.

Check it at the source: DOL foreign labor disclosure data.

Layoff notices: WARN layoff notice became public on 1 Oct 2024

Bristol-Myers Squibb filed a WARN layoff notice covering 79 workers within 30 days (Lawrenceville, NJ).

Notices in the window
1
Workers named
79
Window
1 Sep 2024 to 1 Oct 2024

Fires on a WARN notice after 30 days without one; notices within 30 days are summed.

Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

Timeline

Changes and notable records, by the date each became public

  1. 12 Nov 2026Hiring change

    had 41 H-1B/E-3 visa applications certified in August 2026, 4.6× the same month last year.

    Same month last year: 9; its normal month is 12.

    See the evidence
    This period
    41 (August 2026)
    Normal month (median of 5 earlier)
    12
    Typical spread (median absolute deviation)
    3
    How far from its usual level
    +6.5
    Same month last year
    9
    History used
    2,520 days
    2021-08-01: 182022-08-01: 102023-08-01: 202024-08-01: 122025-08-01: 92026-08-01: 41
    August 20265 earlier monthsnormal: 12

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 9+ earlier periods, 365+ days of history and a value of at least 20.

    Check it at the source: DOL foreign labor disclosure data.

  2. 21 Oct 2026Lobbying change

    lobbying on a new issue.

    See the evidence
    New
    ['DEF']
    Rule
    only points whose every posting (and value revision) is at or before as_of
    Field
    issue_codes
    Metric
    lobbying.filings_count
    Point id
    4288795
  3. 1 Oct 2026Layoff notices change

    filed a WARN layoff notice covering 265 workers within 30 days (Princeton, NJ).

    See the evidence (1 source record)
    Notices in the window
    1
    Workers named
    265
    Window
    1 Sep 2026 to 1 Oct 2026

    Fires on a WARN notice after 30 days without one; notices within 30 days are summed.

  4. 1 Oct 2026Layoff notices record

    WARN notice: Bristol Myers Squibb, 265 workers, Princeton, NJ (dated 1 Sep 2026)

  5. 26 Aug 2026Short interest and volume change

    had 45.9M shares sold short in the 14 Aug 2026 report, 1.5× the same report last year.

    Same report last year: 29.7M; its normal report is 32.2M.

    See the evidence
    This period
    45.9M (the 14 Aug 2026 report)
    Normal report (median of 24 earlier)
    32.2M
    Typical spread (median absolute deviation)
    2.5M
    How far from its usual level
    +3.7
    Same report last year
    29.7M
    History used
    3,150 days
    2025-08-15: 29.7M2025-08-29: 31.2M2025-09-15: 29.5M2025-09-30: 26.3M2025-10-15: 30.4M2025-10-31: 32.1M2025-11-14: 31.7M2025-11-28: 33.9M2025-12-15: 35.4M2025-12-31: 36.6M2026-01-15: 37.0M2026-01-30: 29.9M2026-02-13: 31.7M2026-02-27: 33.4M2026-03-13: 29.9M2026-03-31: 31.5M2026-04-15: 32.4M2026-04-30: 31.3M2026-05-15: 36.7M2026-05-29: 38.5M2026-06-15: 39.6M2026-06-30: 40.5M2026-07-15: 44.9M2026-07-31: 52.3M2026-08-14: 45.9M
    the 14 Aug 2026 report24 earlier reportsnormal: 32.2M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  6. 18 Aug 2026several at once

    drew 6,796 Wikipedia page views in the week of 3 Aug 2026, 2.3× the same week last year; it also had 52.3M shares sold short in the 31 Jul 2026 report, 1.7× the same report last year; it also filed a WARN layoff notice covering 265 workers within 30 days (Princeton, NJ); it also lobbying on a new issue; and it had 41 H-1B/E-3 visa applications certified in August 2026, 4.6× the same month last year. Five unrelated kinds of activity within 93 days.

    See the evidence (6 changes)

    Attention: Wikipedia attention spike became public on 11 Aug 2026

    Bristol-Myers Squibb drew 6,796 Wikipedia page views in the week of 3 Aug 2026, 2.3× the same week last year.

    This period
    6,796 (the week of 3 Aug 2026)
    Normal week (median of 26 earlier)
    2,177
    Typical spread (median absolute deviation)
    104
    How far from its usual level
    +21.2
    Same week last year
    2,895
    History used
    2,777 days
    2026-02-02: 2,6462026-02-09: 2,1912026-02-16: 1,9902026-02-23: 2,2052026-03-02: 2,1142026-03-09: 2,2202026-03-16: 2,0742026-03-23: 2,1142026-03-30: 2,0842026-04-06: 2,1062026-04-13: 2,2472026-04-20: 2,1632026-04-27: 2,4562026-05-04: 2,2942026-05-11: 2,6792026-05-18: 2,4152026-05-25: 2,0712026-06-01: 2,1222026-06-08: 2,2172026-06-15: 1,8382026-06-22: 1,8172026-06-29: 1,9972026-07-06: 2,0812026-07-13: 2,2872026-07-20: 2,4832026-07-27: 2,8902026-08-03: 6,796
    the week of 3 Aug 202626 earlier weeksnormal: 2,177

    Fires when the period is at least 5.0 robust standard deviations above the company's own median, with 20+ earlier periods, 365+ days of history and a value of at least 5,000.

    Check it at the source: Wikimedia page view statistics.

    Short interest and volume: Short interest spike became public on 12 Aug 2026

    Bristol-Myers Squibb had 52.3M shares sold short in the 31 Jul 2026 report, 1.7× the same report last year.

    This period
    52.3M (the 31 Jul 2026 report)
    Normal report (median of 24 earlier)
    31.9M
    Typical spread (median absolute deviation)
    2.0M
    How far from its usual level
    +6.4
    Same report last year
    30.9M
    History used
    3,136 days
    2025-07-31: 30.9M2025-08-15: 29.7M2025-08-29: 31.2M2025-09-15: 29.5M2025-09-30: 26.3M2025-10-15: 30.4M2025-10-31: 32.1M2025-11-14: 31.7M2025-11-28: 33.9M2025-12-15: 35.4M2025-12-31: 36.6M2026-01-15: 37.0M2026-01-30: 29.9M2026-02-13: 31.7M2026-02-27: 33.4M2026-03-13: 29.9M2026-03-31: 31.5M2026-04-15: 32.4M2026-04-30: 31.3M2026-05-15: 36.7M2026-05-29: 38.5M2026-06-15: 39.6M2026-06-30: 40.5M2026-07-15: 44.9M2026-07-31: 52.3M
    the 31 Jul 2026 report24 earlier reportsnormal: 31.9M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Short interest and volume: Short interest spike became public on 26 Aug 2026

    Bristol-Myers Squibb had 45.9M shares sold short in the 14 Aug 2026 report, 1.5× the same report last year.

    This period
    45.9M (the 14 Aug 2026 report)
    Normal report (median of 24 earlier)
    32.2M
    Typical spread (median absolute deviation)
    2.5M
    How far from its usual level
    +3.7
    Same report last year
    29.7M
    History used
    3,150 days
    2025-08-15: 29.7M2025-08-29: 31.2M2025-09-15: 29.5M2025-09-30: 26.3M2025-10-15: 30.4M2025-10-31: 32.1M2025-11-14: 31.7M2025-11-28: 33.9M2025-12-15: 35.4M2025-12-31: 36.6M2026-01-15: 37.0M2026-01-30: 29.9M2026-02-13: 31.7M2026-02-27: 33.4M2026-03-13: 29.9M2026-03-31: 31.5M2026-04-15: 32.4M2026-04-30: 31.3M2026-05-15: 36.7M2026-05-29: 38.5M2026-06-15: 39.6M2026-06-30: 40.5M2026-07-15: 44.9M2026-07-31: 52.3M2026-08-14: 45.9M
    the 14 Aug 2026 report24 earlier reportsnormal: 32.2M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Layoff notices: WARN layoff notice became public on 1 Oct 2026

    Bristol-Myers Squibb filed a WARN layoff notice covering 265 workers within 30 days (Princeton, NJ).

    Notices in the window
    1
    Workers named
    265
    Window
    1 Sep 2026 to 1 Oct 2026

    Fires on a WARN notice after 30 days without one; notices within 30 days are summed.

    Lobbying: Lobbying on a new issue became public on 21 Oct 2026

    Bristol-Myers Squibb lobbying on a new issue.

    New
    ['DEF']
    Rule
    only points whose every posting (and value revision) is at or before as_of
    Field
    issue_codes
    Metric
    lobbying.filings_count
    Point id
    4288795

    Hiring: H-1B/E-3 applications change became public on 12 Nov 2026

    Bristol-Myers Squibb had 41 H-1B/E-3 visa applications certified in August 2026, 4.6× the same month last year.

    This period
    41 (August 2026)
    Normal month (median of 5 earlier)
    12
    Typical spread (median absolute deviation)
    3
    How far from its usual level
    +6.5
    Same month last year
    9
    History used
    2,520 days
    2021-08-01: 182022-08-01: 102023-08-01: 202024-08-01: 122025-08-01: 92026-08-01: 41
    August 20265 earlier monthsnormal: 12

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 9+ earlier periods, 365+ days of history and a value of at least 20.

    Check it at the source: DOL foreign labor disclosure data.

    Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

  7. 12 Aug 2026Short interest and volume change

    had 52.3M shares sold short in the 31 Jul 2026 report, 1.7× the same report last year.

    Same report last year: 30.9M; its normal report is 31.9M.

    See the evidence
    This period
    52.3M (the 31 Jul 2026 report)
    Normal report (median of 24 earlier)
    31.9M
    Typical spread (median absolute deviation)
    2.0M
    How far from its usual level
    +6.4
    Same report last year
    30.9M
    History used
    3,136 days
    2025-07-31: 30.9M2025-08-15: 29.7M2025-08-29: 31.2M2025-09-15: 29.5M2025-09-30: 26.3M2025-10-15: 30.4M2025-10-31: 32.1M2025-11-14: 31.7M2025-11-28: 33.9M2025-12-15: 35.4M2025-12-31: 36.6M2026-01-15: 37.0M2026-01-30: 29.9M2026-02-13: 31.7M2026-02-27: 33.4M2026-03-13: 29.9M2026-03-31: 31.5M2026-04-15: 32.4M2026-04-30: 31.3M2026-05-15: 36.7M2026-05-29: 38.5M2026-06-15: 39.6M2026-06-30: 40.5M2026-07-15: 44.9M2026-07-31: 52.3M
    the 31 Jul 2026 report24 earlier reportsnormal: 31.9M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  8. 11 Aug 2026Attention change

    drew 6,796 Wikipedia page views in the week of 3 Aug 2026, 2.3× the same week last year.

    Same week last year: 2,895; its normal week is 2,177.

    See the evidence
    This period
    6,796 (the week of 3 Aug 2026)
    Normal week (median of 26 earlier)
    2,177
    Typical spread (median absolute deviation)
    104
    How far from its usual level
    +21.2
    Same week last year
    2,895
    History used
    2,777 days
    2026-02-02: 2,6462026-02-09: 2,1912026-02-16: 1,9902026-02-23: 2,2052026-03-02: 2,1142026-03-09: 2,2202026-03-16: 2,0742026-03-23: 2,1142026-03-30: 2,0842026-04-06: 2,1062026-04-13: 2,2472026-04-20: 2,1632026-04-27: 2,4562026-05-04: 2,2942026-05-11: 2,6792026-05-18: 2,4152026-05-25: 2,0712026-06-01: 2,1222026-06-08: 2,2172026-06-15: 1,8382026-06-22: 1,8172026-06-29: 1,9972026-07-06: 2,0812026-07-13: 2,2872026-07-20: 2,4832026-07-27: 2,8902026-08-03: 6,796
    the week of 3 Aug 202626 earlier weeksnormal: 2,177

    Fires when the period is at least 5.0 robust standard deviations above the company's own median, with 20+ earlier periods, 365+ days of history and a value of at least 5,000.

    Check it at the source: Wikimedia page view statistics.

  9. 4 Aug 2026Lobbying record

    BRISTOL-MYERS SQUIBB COMPANY: new lobbying registration (ADVANCED POLICY CONSULTING, LLC) (dated 1 Jul 2026)

  10. 7 Jul 2026Lobbying change

    lobbying on a new issue.

    See the evidence
    New
    ['MED']
    Rule
    only points whose every posting (and value revision) is at or before as_of
    Field
    issue_codes
    Metric
    lobbying.filings_count
    Point id
    4685865
  11. 29 Jun 2026Lobbying record

    BRISTOL MYERS SQUIBB: new lobbying registration (ALEXANDER J. BECKLES, L.L.C.) (dated 1 Feb 2026)

  12. 1 May 2026Layoff notices change

    filed a WARN layoff notice covering 206 workers within 30 days (Lawrence Twp, NJ).

    See the evidence (1 source record)
    Notices in the window
    1
    Workers named
    206
    Window
    1 Apr 2026 to 1 May 2026

    Fires on a WARN notice after 30 days without one; notices within 30 days are summed.

  13. 1 May 2026Layoff notices record

    WARN notice: Bristol Myers Squibb, 206 workers, Lawrence Twp, NJ (dated 1 Apr 2026)

  14. 19 Apr 2026Lobbying record

    BRISTOL-MYERS SQUIBB: lobbying engagement terminated (CROSSROADS STRATEGIES, LLC) (dated 1 Jan 2026)

  15. 1 Mar 2026Layoff notices change

    filed a WARN layoff notice covering 247 workers within 30 days (Lawrence Twp, NJ).

    See the evidence (1 source record)
    Notices in the window
    1
    Workers named
    247
    Window
    30 Jan 2026 to 1 Mar 2026

    Fires on a WARN notice after 30 days without one; notices within 30 days are summed.

  16. 1 Mar 2026Layoff notices record

    WARN notice: Bristol Myers Squibb, 247 workers, Lawrence Twp, NJ (dated 1 Feb 2026)

  17. 25 Feb 2026Lobbying record

    BRISTOL-MYERS SQUIBB: new lobbying registration (CAPITOL COUNSEL LLC) (dated 1 Feb 2026)

  18. 24 Feb 2026Lobbying record

    BRISTOL-MYERS SQUIBB COMPANY: new lobbying registration (MARSHALL & POPP, LLC) (dated 19 Feb 2026)

  19. 23 Feb 2026Lobbying record

    BRISTOL-MYERS SQUIBB COMPANY: new lobbying registration (AVENUE SOLUTIONS) (dated 1 Jan 2026)

  20. 18 Feb 2026Lobbying record

    BRISTOL-MYERS SQUIBB COMPANY: new lobbying registration (W STRATEGIES, LLC) (dated 1 Feb 2026)

  21. 1 Dec 2025Layoff notices change

    filed a WARN layoff notice covering 110 workers within 30 days (Lawrence Twp, NJ).

    See the evidence (1 source record)
    Notices in the window
    1
    Workers named
    110
    Window
    1 Nov 2025 to 1 Dec 2025

    Fires on a WARN notice after 30 days without one; notices within 30 days are summed.

  22. 1 Dec 2025Layoff notices record

    WARN notice: Bristol Myers Squibb (BMS), 110 workers, Lawrence Twp, NJ (dated 1 Nov 2025)

  23. 6 Oct 2025Lobbying record

    BRISTOL-MYERS SQUIBB COMPANY: new lobbying registration (MILLER STRATEGIES, LLC) (dated 1 Sep 2025)

  24. 1 Oct 2025several at once

    had 44 H-1B/E-3 visa applications certified in June 2025, 2.9× the same month last year, while it filed a WARN layoff notice covering 282 workers within 30 days (Lawrence Twp, NJ). Two unrelated kinds of activity within 28 days.

    See the evidence (2 changes)

    Hiring: H-1B/E-3 applications change became public on 31 Aug 2025

    Bristol-Myers Squibb had 44 H-1B/E-3 visa applications certified in June 2025, 2.9× the same month last year.

    This period
    44 (June 2025)
    Normal month (median of 5 earlier)
    15
    Typical spread (median absolute deviation)
    3
    How far from its usual level
    +6.5
    Same month last year
    15
    History used
    2,093 days
    2020-06-01: 102021-06-01: 232022-06-01: 122023-06-01: 182024-06-01: 152025-06-01: 44
    June 20255 earlier monthsnormal: 15

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 9+ earlier periods, 365+ days of history and a value of at least 20.

    Check it at the source: DOL foreign labor disclosure data.

    Layoff notices: WARN layoff notice became public on 1 Oct 2025

    Bristol-Myers Squibb filed a WARN layoff notice covering 282 workers within 30 days (Lawrence Twp, NJ).

    Notices in the window
    1
    Workers named
    282
    Window
    1 Sep 2025 to 1 Oct 2025

    Fires on a WARN notice after 30 days without one; notices within 30 days are summed.

    Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

  25. 1 Oct 2025Layoff notices change

    filed a WARN layoff notice covering 282 workers within 30 days (Lawrence Twp, NJ).

    See the evidence (1 source record)
    Notices in the window
    1
    Workers named
    282
    Window
    1 Sep 2025 to 1 Oct 2025

    Fires on a WARN notice after 30 days without one; notices within 30 days are summed.

  26. 1 Oct 2025Layoff notices record

    WARN notice: Bristol Myers Squibb (BMS), 282 workers, Lawrence Twp, NJ (dated 1 Sep 2025)

  27. 31 Aug 2025Hiring change

    had 44 H-1B/E-3 visa applications certified in June 2025, 2.9× the same month last year.

    Same month last year: 15; its normal month is 15.

    See the evidence
    This period
    44 (June 2025)
    Normal month (median of 5 earlier)
    15
    Typical spread (median absolute deviation)
    3
    How far from its usual level
    +6.5
    Same month last year
    15
    History used
    2,093 days
    2020-06-01: 102021-06-01: 232022-06-01: 122023-06-01: 182024-06-01: 152025-06-01: 44
    June 20255 earlier monthsnormal: 15

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 9+ earlier periods, 365+ days of history and a value of at least 20.

    Check it at the source: DOL foreign labor disclosure data.

  28. 14 Aug 2025Institutional holdings record

    Qube Research & Technologies Ltd opened a $451.0M position (2025Q2 13F)

  29. 28 Jul 2025Lobbying record

    BRISTOL-MYERS SQUIBB: new lobbying registration (THE MCMANUS GROUP) (dated 1 Jul 2025)

  30. 25 Jul 2025Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  31. 25 Jul 2025Filings record

    Director or officer change

  32. 1 Jul 2025Layoff notices change

    filed a WARN layoff notice covering 68 workers within 30 days (Lawrence Twp, NJ).

    See the evidence (1 source record)
    Notices in the window
    1
    Workers named
    68
    Window
    1 Jun 2025 to 1 Jul 2025

    Fires on a WARN notice after 30 days without one; notices within 30 days are summed.

  33. 1 Jul 2025Layoff notices record

    WARN notice: Bristol Myers Squibb (BMS), 68 workers, Lawrence Twp, NJ (dated 1 Jun 2025)

  34. 1 Jun 2025Layoff notices record

    WARN notice: Bristol Myers Squibb (BMS), 516 workers, Lawrence Twp, NJ (dated 1 May 2025)

  35. 3 May 2025Layoff notices change

    filed a WARN layoff notice covering 133 workers within 30 days.

    See the evidence (1 source record)
    Notices in the window
    1
    Workers named
    133
    Window
    3 Apr 2025 to 3 May 2025

    Fires on a WARN notice after 30 days without one; notices within 30 days are summed.

  36. 3 May 2025Layoff notices record

    WARN notice (layoff): Bristol Myers Squibb, 133 workers, Libertyville, IL (dated 2 May 2025)

  37. 30 Apr 2025Insiders record

    Hirawat Samit (EVP,Chief Med.Offr.,Drug Dev.) bought 4,250 shares of BMY ($202,215) (dated 29 Apr 2025)

  38. 17 Mar 2025Lobbying record

    TIBER CREEK GROUP (ON BEHALF OF BRISTOL MYERS SQUIBB): lobbying engagement terminated (TIBER CREEK HEALTH STRATEGIES, INC.) (dated 28 Feb 2025)

  39. 17 Mar 2025Lobbying record

    BRISTOL MYERS SQUIBB: lobbying engagement terminated (TIBER CREEK GROUP) (dated 28 Feb 2025)

  40. 1 Mar 2025Layoff notices change

    filed a WARN layoff notice covering 290 workers within 30 days (Lawrence Twp, NJ).

    See the evidence (1 source record)
    Notices in the window
    1
    Workers named
    290
    Window
    30 Jan 2025 to 1 Mar 2025

    Fires on a WARN notice after 30 days without one; notices within 30 days are summed.

Showing the newest 40 of 196 entries; narrow the window or the kind of data to see older ones.

Not listed: 250 routine records (quarterly and annual reports, results releases, other 8-K items, material agreements and individual insider sales), counted over all history.

Identifiers and sources

How records are matched to this company, and what each source holds for it

Cik
0000014272
Ticker
BMY
Domain
bms.com
Employer name
adnexus a bristol myers squibb rd, Bristol-Myers Squibb Company, E.R. Squibb & Sons LLC, turning point therapeutics (4 unverified)
Fein
13-6121983 (1 unverified)
Hq location
NJ|PRINCETON|08543 (1 unverified)
Lobbying client
bristol myers squibb, bristol myers squibb australia, juno therapeutics, karuna therapeutics and 1 more
Name
1096271 BC ULC, 2seventy bio, Inc, 2seventy bio Securities Corporation, 345 Park LLC and 213 more
Wikidata
Q266423
Wikipedia
Bristol Myers Squibb
  • DOL H-1B labor condition applications and PERM certifications1722 data points7 Oct 2019 to 28 Sep 2026
  • Federal lobbying disclosures (LDA)134 records, 279 data points30 Dec 1899 to 30 Sep 2026
  • SEC Form 13F institutional holdings9 records, 481 data points30 Jun 2013 to 30 Sep 2026
  • SEC EDGAR filings (8-K items, S-1, Form D, 10-K/10-Q)205 records12 Jan 2016 to 29 Oct 2026
  • SEC XBRL company facts (revenue, capex, R&D, backlog...)1256 data points31 Dec 2006 to 21 Oct 2026
  • SEC Form 4 insider transactions104 records, 336 data points6 Jan 2016 to 6 Nov 2026
  • FINRA short interest (twice monthly)636 data points29 Dec 2017 to 30 Oct 2026
  • FINRA daily short sale volume (off-exchange)4178 data points1 Aug 2018 to 20 Nov 2026
  • WARN layoff notices (state labor agencies)22 records, 60 data points1 Nov 2004 to 1 Sep 2026
  • Wikipedia pageviews2882 data points1 Jan 2019 to 21 Nov 2026